Table 2. Clinical and Molecular Characteristics of IDH-Mutated ET Patients.
UPN | Age | G | IDH | JAK2 (allele burden) | FU | OS | Drug | Survival |
---|---|---|---|---|---|---|---|---|
1 | 55 | M | IDH1 R132C | (-) | 64 | 64 | Hydroxyurea, ASA | Alive |
2 | 33 | F | IDH2 R140Q | (+) (5%) | 52 | 60 | Hydroxyurea | Alive |
UPN indicates unique patient number. G: gender; F: female; M: male; FU: follow-up (months); OS: overall survival (months).